Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea
GC Cell Corporation
GC Cell Corporation
Hospices Civils de Lyon
European Organisation for Research and Treatment of Cancer - EORTC
Cordgenics, LLC
Denovo Biopharma LLC
Sumitomo Pharma America, Inc.
Canadian Cancer Trials Group
Henry Ford Health System
AbbVie
Rennes University Hospital
Wake Forest University Health Sciences
European Organisation for Research and Treatment of Cancer - EORTC
Assistance Publique - Hôpitaux de Paris
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
Vascular Biogenics Ltd. operating as VBL Therapeutics
Celldex Therapeutics
Hoffmann-La Roche
University Hospital, Bonn
Merck Sharp & Dohme LLC
NovoCure Ltd.
AstraZeneca
National Institutes of Health Clinical Center (CC)
International Atomic Energy Agency
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Radiation Therapy Oncology Group
SWOG Cancer Research Network
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Pfizer
NovoCure Ltd.
Heidelberg University
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
National Institute of Neurology and Neurosurgery, Mexico
Pfizer
Assistance Publique - Hôpitaux de Paris